Bioventus (BVS) Return on Invested Capital (2021 - 2026)

Bioventus' Return on Invested Capital history runs 6 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Invested Capital rose 2.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 2.0% YoY) and the FY2025 annual result came in at 0.03%, up 3.0% from the prior year.
• Return on Invested Capital was 0.01% for Q1 2026 at Bioventus, up from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q1 2026 and bottomed at 0.02% in Q2 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2022 — Return on Invested Capital slipped 2 bps — and 2024, when it grew 2 bps.
• Bioventus' Return on Invested Capital stood at 0.01% in 2022, then surged by 38 bps to 0.01% in 2023, then soared by 86 bps to 0.0% in 2024, then jumped by 1277 bps to 0.01% in 2025, then gained by 8 bps to 0.01% in 2026.
• Business Quant data shows BVS's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.